Neca

Neca

SCHEMBL30656108

CCNC(=O)[C@H]1OC(n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 1.00
ADORA3 P0DMS8 4/20 1.00
ADORA2A P29274 4/20 1.00
HSP90AA1 P07900 3/20 1.00
HSP90B1 P14625 3/20 1.00
ADORA2B P29275 3/20 1.00
ADORA1 P30542 3/20 1.00
MAPK1 P28482 2/20 1.00
KMT2A Q03164 2/20 1.00
CYP2C19 P33261 1/20 1.00
TMIGD3 P0DMS9 1/20 1.00
RXFP1 Q9HBX9 1/20 1.00
MEN1 O00255 1/20 1.00
CYP2C9 P11712 1/20 1.00
AHCY P23526 1/20 0.81
LMNA P02545 1/20 0.78
THRB P10828 1/20 0.78
BLM P54132 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Neca SCHEMBL19928417 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL12119012 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL19928418 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL16585523 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL18089301 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL29361791 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
Neca SCHEMBL30036568 1.00 TSHR (1.00) TSHRADORA3ADORA2AHSP90AA1HSP90B1
SCHEMBL25046624 0.91 AHCY (0.83) TSHRADORA3ADORA2AHSP90AA1HSP90B1
SCHEMBL31617851 0.91 AHCY (0.83) TSHRADORA3ADORA2AHSP90AA1HSP90B1
SCHEMBL16378787 0.89 ADORA3 (0.80) TSHRADORA3ADORA2AHSP90AA1HSP90B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4447962-A1 ADENOSINE 2A RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF CANCER UNIVERSITE DE GENEVE (CH) 2024-10-23 EP disclosed
WO-2023213761-A1 ADENOSINE 2A RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF CANCER UNIVERSITE DE GENEVE (CH) 2023-11-09 WO disclosed